Press-release for stocks related to pharma

Prices are updated after-hours

tags : Pharma crawled time : 15:00

save search

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma management for

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.469 3.08% 2.99% 4.8K

Health Technology

| Email alert Add to watchlist
pharma key

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
HUGE | News | $0.469 -4.09% -4.26% 110K

Process Industries

| -20.6% | O: -1.51% H: 5.48% C: -0.56%
pharma nasdaq

Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
NBIO | $0.0898 15.32% 190K

| -34.31% | O: -13.87% H: 20.93% C: 17.8%
pharma transdermal system

Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
Published: 2024-02-15 (Crawled : 15:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K

Health Technology

| 41.23% | O: -0.25% H: 3.17% C: -0.74%
pharma drug unique tumor program

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2024
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
INZY | $4.42 0.68% 0.68% 740K

Health Technology

| -16.86% | O: 0.0% H: 2.45% C: 2.08%
pharma nasdaq grants

ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
EPIX | $6.475 1.17% 1.16% 130K

Health Technology

| -36.06% | O: 2.4% H: 3.8% C: 2.83%
pharma conference life sciences

Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
Published: 2024-02-01 (Crawled : 15:00) - globenewswire.com
SILO | $1.8 -9.55% -10.56% 5.2M

Finance and Insurance

| 28.39% | O: -2.58% H: 3.97% C: 3.97%
pharma pipeline

Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIIIInvestor Call with CEO, George Magrath, M.D., M.B.A., M.S. on December 5, 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
OCUP | News | $1.53 1.33% 1.31% 140K

Health Technology

| -44.89% | O: 3.28% H: 8.48% C: 7.77%
pharma presentation innovation

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K

Health Technology

| 46.29% | O: 2.81% H: 0.0% C: -1.74%
lp-284 fda pharma drug candidate designation lymphomas grants

Noema Pharma Appoints Robert Lasser, M.D., as Chief Medical Officer
Published: 2023-11-15 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.98% | O: -0.15% H: 0.0% C: 0.0%
pharma medical

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILDMultiple centers in the U.S. are open for enrollment
Published: 2023-10-31 (Crawled : 15:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K

Health Technology

| 31.2% | O: -0.8% H: 2.42% C: 0.81%
pharma efzofitimod study

Acasti Pharma to Host KOL Event on GTX-104: A Potential New Treatment Standard for Rare and Life-Threatening aneurysmal Subarachnoid Hemorrhage (aSAH)Virtual Webinar to Take Place October 11, 2023 at 2:00pm ET
Published: 2023-10-04 (Crawled : 15:00) - biospace.com/
ACST | $2.86 0.35% 0.35% 4.5K

Health Technology

| 7.14% | O: -0.75% H: 5.3% C: -1.89%
gtx-104 rare pharma treatment potential

Total number of shares and voting rights in Zealand Pharma at September 29, 2023
Published: 2023-09-29 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma total

Lantern Pharma Announces First Patient Dosed in the Phase 1 Study for LP-184 in Advanced Solid Tumors
Published: 2023-09-25 (Crawled : 15:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K

Health Technology

| 56.57% | O: 0.18% H: 6.01% C: -4.1%
lp-184 pharma tumors study

Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
Published: 2023-08-14 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma conference results

J&J, Astellas Join Pharma Lawsuits Over Medicare Drug Price Negotiations
Published: 2023-07-19 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology